传染病防控视角下耐多药及广泛耐药结核病患者交通出行的立法思考

doi:10.3969/j.issn.1000-6621.2020.12.003

中国防痨杂志 ›› 2020, Vol. 42 ›› Issue (12): 1268-1271.doi: 10.3969/j.issn.1000-6621.2020.12.003

传染病防控视角下耐多药及广泛耐药结核病患者交通出行的立法思考

孙明雷^*, 关黎, 赵娟, 王晨, 邹丹丹, 梁立波()

150081 哈尔滨医科大学卫生管理学院社会医学教研室(孙明雷、赵娟、王晨、邹丹丹、梁立波);黑龙江省传染病防治院党政办公室(关黎)

收稿日期:2020-07-30 出版日期:2020-12-10 发布日期:2020-12-24
通信作者: 梁立波 E-mail:llbhit@163.com
基金资助:
国家自然科学基金(71974049)

Legislative considerations on traffic travel of MDR-TB/XDR-TB patients from the perspective of infectious disease prevention and control

SUN Ming-lei^*, GUAN Li, ZHAO Juan, WANG Chen, ZOU Dan-dan, LIANG Li-bo()

^*Department of Social Medicine, Health Management College of Harbin Medical University, Harbin 150081, China

Received:2020-07-30 Online:2020-12-10 Published:2020-12-24
Contact: LIANG Li-bo E-mail:llbhit@163.com

摘要/Abstract

摘要：

耐多药及广泛耐药结核病(MDR-TB/XDR-TB)患者流动始终是结核病防控的重大难题,活动性MDR-TB/XDR-TB患者乘坐公共交通工具出行可能增加结核分枝杆菌的传播概率,亟需从立法的角度对交通出行的MDR-TB/XDR-TB患者进行管控,制定及完善MDR-TB/XDR-TB患者出行的法律法规,以互联网及大数据为支撑实现多部门、多领域对于MDR-TB/XDR-TB患者的信息共享及联网追踪,充分发挥基本公共卫生及基层医疗机构的积极作用,完善对MDR-TB/XDR-TB患者登记、上报、出行及治疗情况记录,以及构建监管的动态管理体系。在强有力的法律支撑下,利用网络信息化优势,多部门协同合作,充分发挥结核病患者管理人员及信息监测人员的职能作用,建立完备的患者网络管理流程,推进MDR-TB/XDR-TB患者出行管理及防控工作。

关键词: 传染病控制, 结核,抗多种药物性, 泛耐药结核病, 立法,医学, 公共卫生管理

Abstract:

MDR-TB and XDR-TB patients have always been a major problem in the prevention and control of tuberculosis. Travel by public transportation for MDR-TB/XDR-TB patients during the active period may increase the probability of transmission of tuberculosis. There is an urgent need to control MDR-TB/XDR-TB patients on traffic from a legislative perspective. Formulate and improve the travel laws and regulations for MDR-TB/XDR-TB patients, use the internet and big data as the support to realize the information sharing and online tracking of MDR-TB/XDR-TB patients in multiple departments and fields, and give full play to the active role of basic public health and primary medical institutions to achieve dynamic management of MDR-TB/XDR-TB patients. Improve the dynamic management system for registration, reporting, travel and treatment records and supervision of MDR-TB/XDR-TB patients. With strong legal support, using the advantages of network information technology, multiple departments coordinated and cooperated, give full play to the functions of tuberculosis patient management personnel and information monitoring personnel, and establish a complete patient network management procedure to promote the management and prevention and control of travel of patients with MDR-TB/XDR-TB.

Key words: Communicable disease control, Tuberculosis,multidrug-resistant, Extensively drug-resistant tuberculosis, Legislation,medical, Public health administration

孙明雷, 关黎, 赵娟, 王晨, 邹丹丹, 梁立波. 传染病防控视角下耐多药及广泛耐药结核病患者交通出行的立法思考[J]. 中国防痨杂志, 2020, 42(12): 1268-1271. doi: 10.3969/j.issn.1000-6621.2020.12.003

SUN Ming-lei, GUAN Li, ZHAO Juan, WANG Chen, ZOU Dan-dan, LIANG Li-bo. Legislative considerations on traffic travel of MDR-TB/XDR-TB patients from the perspective of infectious disease prevention and control[J]. Chinese Journal of Antituberculosis, 2020, 42(12): 1268-1271. doi: 10.3969/j.issn.1000-6621.2020.12.003

参考文献 22

[1]	Farmer PE. Better and safer treatment for multidrug-resistant tuberculosis. Lancet, 2018,392(10150):798-800. doi: 10.1016/S0140-6736(18)32149-4. doi: 10.1016/S0140-6736(18)32149-4 URL pmid: 30215368
[2]	Orenstein EW, Basu S, Shah NS, et al. Treatment outcomes among patients with multidrug-resistant tuberculosis: syste-matic review and meta-analysis. Lancet Infect Dis, 2009,9(3):153-161. doi: 10.1016/S1473-3099(09)70041-6. doi: 10.1016/S1473-3099(09)70041-6 URL
[3]	World Health Organization. Global tuberculosis report 2019. Geneva: World Health Organization, 2019.
[4]	Eshetie S, Alebel A, Wagnew F, et al. Current treatment of multidrug resistant tuberculosis in Ethiopia: an aggregated and individual patients’ data analysis for outcome and effectiveness of the current regimens. BMC Infect Dis, 2018,18(1):486. doi: 10.1186/s12879-018-3401-5. doi: 10.1186/s12879-018-3401-5 URL pmid: 30261852
[5]	Lange C, Chesov D, Furin J, et al. Revising the definition of extensively drug-resistant tuberculosis. Lancet Respir Med, 2018,6(12):893-895. doi: 10.1016/S2213-2600(18)30428-4. doi: 10.1016/S2213-2600(18)30428-4 URL pmid: 30420247
[6]	Makhado NA, Matabane E, Faccin M, et al. Outbreak of multidrug-resistant tuberculosis in South Africa undetected by WHO-endorsed commercial tests: an observational study. Lancet Infect Dis, 2018,18(12):1350-1359. doi: 10.1016/S1473-3099(18)30496-1. doi: 10.1016/S1473-3099(18)30496-1 URL pmid: 30342828
[7]	Fox GJ, Schaaf HS, Mandalakas A, et al. Preventing the spread of multidrug-resistant tuberculosis and protecting contacts of infectious cases. Clin Microbiol Infect, 2017,23(3):147-153. doi: 10.1016/j.cmi.2016.08.024. doi: 10.1016/j.cmi.2016.08.024 URL pmid: 27592087
[8]	段成荣, 吕利丹, 邹湘江. 当前我国流动人口面临的主要问题和对策——基于2010年第六次全国人口普查数据的分析. 人口研究, 2013,37(2):17-24.
[9]	高向东. 中国流动人口省际迁移距离及变化. 人口研究, 2018,42(6):25-34.
[10]	雷娟. 美国传染病强制医疗制度及启示. 比较法研究, 2014(6):157-169.
[11]	台海网. 台湾一对结核病夫妻赴大陆探亲[EB/OL]. [2020-07-20]. http://www.taihainet.com/news/twnews/bilateral/2007-07-26/153344.html.
[12]	World Health Organization. Tuberculosis and air travel-Guidelines for prevention and control. Geneva: World Health Organization, 2006.
[13]	Gittler J. Controlling resurgent tuberculosis: public health agencies, public policy, and law. J Health Polit Policy Law, 1994,19(1):107-147. doi: 10.1215/03616878-19-1-107. doi: 10.1215/03616878-19-1-107 URL pmid: 8014405
[14]	Fallow HA. Reforming federal quarantine law in the wake of Andrew Speaker: the “tuberculosis traveler”. J Contemp Health Law Policy, 2008,25(1):83-106. URL pmid: 19137748
[15]	陈诚. 耐多药结核病治疗管理制度政策调查分析. 北京: 中国疾病预防控制中心, 2009.
[16]	U.S. Center for Disease Control and Prevention. TB Incidence in the United States, 1953—2018[EB/OL]. [2020-10-24]. https://www.cdc.gov/tb/statistics/tbcases.htm.
[17]	中华人民共和国卫生部. 中华人民共和国传染病防治法实施办法.中华人民共和国卫生部令(第17号). 1991-12-06.
[18]	肖和平. 立法管理结核病传染源刻不容缓. 中国防痨杂志, 2015,37(9):921-922. doi: 10.3969/j.issn.1000-6621.2015.05.001. doi: 10.3969/j.issn.1000-6621.2015.05.001 URL
[19]	李雪峰. 健全国家突发公共卫生事件应急管理体系的对策研究. 行政管理改革, 2020(4):13-21. doi: CNKI:SUN:XZGL.0.2020-04-002.
[20]	方勇, 肖和平. 结核感染猛于虎 “防-管-扶-法”可驯服. 中国防痨杂志, 2018,40(1):14-16. doi: 10.3969/j.issn.1000-6621.2018.01.005.
[21]	中华人民共和国卫生部. 结核病防治管理办法. 卫生部令(第92号). 2013-02-20.
[22]	央视网. 北京最严社区防控政策来了!严格进出京管理不是“封城”[EB/OL]. [2020-07-20]. http://m.news.cctv.com/2020/06/18/ARTI8sxCPD9ffT2dL1IBEfSY200618.shtml.

传染病防控视角下耐多药及广泛耐药结核病患者交通出行的立法思考

Legislative considerations on traffic travel of MDR-TB/XDR-TB patients from the perspective of infectious disease prevention and control

RichHTML

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献 22

相关文章 15

编辑推荐

Metrics

本文评价

友情链接

[1]	靳鸿建. 我国县级结核病防治服务体系建设及防治工作亟需加强——一位老防痨工作者的意见和建议[J]. 中国防痨杂志, 2020, 42(9): 896-902.
[2]	沈鑫, 沙巍, 刘剑君. 新型冠状病毒肺炎疫情对结核病防控的影响及对策[J]. 中国防痨杂志, 2020, 42(6): 544-548.
[3]	李瑾,郭晓芹,李勇,邹金燕,路丽苹. 2018年上海市松江区本市户籍≥65岁老年人口肺结核主动筛查及其效果分析[J]. 中国防痨杂志, 2020, 42(4): 353-359.
[4]	高谦,梅建. 我国学校结核病预防与控制的思考[J]. 中国防痨杂志, 2020, 42(3): 195-199.
[5]	应若嫣, 黄晓辰, 王洁, 刘一典, 沙巍, 杨华. 耐药MTB分离株对不同组合抗结核药品体外药物敏感性试验的结果分析[J]. 中国防痨杂志, 2020, 42(11): 1183-1182.
[6]	张琳,薛喜桩,李小谋. 2015—2017年西安口岸出入境人员结核病监测情况分析[J]. 中国防痨杂志, 2019, 41(2): 222-226.
[7]	范琳,熊坤龙,肖和平. 建国70年来结核病化学治疗的历史进程要览[J]. 中国防痨杂志, 2019, 41(11): 1145-1148.
[8]	宋银娟,赵德明,周向梅. 牛分枝杆菌引起人结核病的概况和控制[J]. 中国防痨杂志, 2019, 41(10): 1132-1135.
[9]	高谦,梅建,谭卫国. 实事求是抓住核心脚踏实地精准防控[J]. 中国防痨杂志, 2019, 41(10): 1074-1079.
[10]	张曼晖,刘剑君,么鸿雁,王琦琦,孙谨芳,于石成,张慧. 我国肺结核控制目标实现与社会决定因素相关性研究[J]. 中国防痨杂志, 2019, 41(1): 80-87.
[11]	陆唤,黄诚. 2011—2015年上海市崇明区肺结核疫情分析[J]. 中国防痨杂志, 2018, 40(5): 548-552.
[12]	何贵清,孙峰,苏菲菲,施伎蝉,朱海燕,戴建义,杨守峰,宁洪叶,崔小亚,李君桦,蒋贤高,张文宏. 2013—2015年温州市耐多药肺结核患者队列标准化疗方案的治疗转归[J]. 中国防痨杂志, 2018, 40(2): 161-167.
[13]	Jing Bao. 美国结核病疫情现状和控制策略[J]. 中国防痨杂志, 2017, 39(2): 198-201.
[14]	林定文，崔哲哲，潘冬香，等. 基于Flexible 空间扫描统计量的广西学校结核病流行病学分析[J]. 中国防痨杂志, 2017, 39(11): 1212-1217.
[15]	吴腾燕. 德尔菲法在我国结核病防控领域中的应用[J]. 中国防痨杂志, 2016, 38(10): 878-880.